Orion S.A.

Equities

OEC

LU1092234845

Market Closed - Nyse Other stock markets 16:00:02 2025-06-13 EDT			5-day change	1st Jan Change
10.92 ^USD	-3.28%		-3.28%	-30.84%

06-03	US FDA Approves New Indication for Bayer, Orion's Prostate Cancer Treatment	MT
05-29	Hyperscale Data Inc, Orion Terminate Purchase Agreement	RE

Orion S.A., Q1 2024 Earnings Call, May 03, 2024

Published on 2024-05-03 at 08:30

Presentation Operator Message
Operator (Operator)

Ladies and gentlemen, good morning, and welcome to the Orion S.A. First Quarter 2024 Earnings Conference Call. [Operator Instructions]. A brief

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Orion S.A.

US FDA Approves New Indication for Bayer, Orion's Prostate Cancer Treatment	06-03	MT
Hyperscale Data Inc, Orion Terminate Purchase Agreement	05-29	RE
Orion Joins NYSE Texas in Dual Listing	05-28	MT
Orion, Shilpa Medicare Enter Commercial Deal for Albumin Product in Europe	05-23	MT
Auking Mining And Orion Sign A$8M Financing Term Sheet With Nebari	05-18	RE
UBS Adjusts Price Target on Orion to $15 From $17, Maintains Buy Rating	05-13	MT
UBS Adjusts Price Target on Orion to $17 From $18, Maintains Buy Rating	05-08	MT
Orion S.A., Q1 2025 Earnings Call, May 08, 2025	05-08
Aktiespararna is adding Orion and Storytel to its small-cap portfolio.	05-08	FW
Orion S.A. Reports Earnings Results for the First Quarter Ended March 31, 2025	05-07	CI
Earnings Flash (OEC) ORION Reports Q1 Adjusted EPS $0.22, vs. FactSet Est of $0.43	05-07	MT
Earnings Flash (OEC) ORION ENGINEERED CARBONS S.A. Posts Q1 Revenue $477.7M, vs. FactSet Est of $485.6M	05-07	MT
Orion to License Criceto's Parkinson's Rescue Spray	04-25	MT
JPMorgan Downgrades Orion to Neutral From Overweight, Adjusts Price Target to $12 From $18	04-24	MT
Orion Affirms FY25 Net Sales, Operating Profit Outlook	04-23	MT
Orion to Invest KRW830 Billion in Production Expansion; Shares Jump 4%	04-15	MT
Orion to Wind Down Finnish Unit	04-15	MT
Mizuho Cuts Price Target on Orion to $15 From $17, Keeps Neutral Rating	03-17	MT
Orion Plans New UK Biologics Research Center	03-10	MT
Orion to Use Aiforia's Software for Preclinical Histology	03-05	MT
Orion Projects FY25 Net Sales, Operating Profit Growth	02-25	MT
Small changes in earnings for Orion (update)	02-25	FW
Small changes in earnings for Orion	02-25	FW
TMS Co., Ltd. Provided Notice on the Status of JX10 (TMS-007) Clinical Trial Application in China	02-21	CI
UBS Trims Price Target on Orion to $22 From $23, Maintains Buy Rating	02-20	MT